| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |